VolitionRx Ltd (VNRX) shareholders
Close on Nov 17, 2026Market cap $2.58MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Armistice Capital, LLC Joint filing with Steven Boyd (9.99%) | 9,343,265 | 9.99% | 13G (passive) amendment | Dec 31, 2024 |
| Fatima Dickey Joint filing with Lagoda Investment Management, L.P. (5.90%), Lagoda Investment Management, LLC (5.90%) | 1,650,505 | 5.90% | 13D (active) amendment | Sep 15, 2026 |
| Lagoda Investment Management, L.P. | 1,627,005 | 14.00% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of VNRX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. | 1,455,950 | 10.67% | $1.97M | +648,500 | 1.08% |
| Luminus Management LLC | 156,897 | 1.15% | $211.81K | +107,147 | 0.14% |
| Geode Capital Management, LLC | 55,537 | 0.41% | $74.99K | −5,967 | 0.00% |
| Vanguard Capital Management LLC | 50,684 | 0.37% | $68.42K | – | 0.00% |
| Wealthspire Advisors, LLC | 45,000 | 0.33% | $60.75K | +34,000 | 0.00% |
| State Street Corp | 33,995 | 0.25% | $45.89K | −2 | 0.00% |
| XTX Topco Ltd | 25,381 | 0.19% | $34.26K | +23,078 | 0.00% |
| Vanguard Fiduciary Trust Co | 25,133 | 0.18% | $33.93K | – | 0.00% |
| BlackRock, Inc. | 22,308 | 0.16% | $30.12K | −1 | 0.00% |
| Northern Trust Corp | 12,978 | 0.10% | $17.52K | −2 | 0.00% |
| Silverberg Bernstein Capital Management LLC | 12,520 | 0.09% | $16.90K | −41 | 0.01% |
| Squarepoint Ops LLC | 10,685 | 0.08% | $14.43K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 5,768 | 0.04% | $7.79K | +3,952 | 0.00% |
| SRS Capital Advisors, Inc. | 5,552 | 0.04% | $7.50K | New | 0.00% |
| UBS Group AG | 4,419 | 0.03% | $5.97K | −5,953 | 0.00% |
| Group One Trading, L.P. | 2,500 | 0.02% | $3.38K | – | 0.00% |
| Simplex Trading, LLC | 2,174 | 0.02% | $2.93K | New | 0.00% |
| Northwestern Mutual Wealth Management Co | 1,999 | 0.01% | $2.70K | −1 | 0.00% |
| Integrated Wealth Concepts LLC | 1,000 | 0.01% | $1.35K | +500 | 0.00% |
| Barclays PLC | 357 | 0.00% | $482 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 25 | 2M | 14.1% | 5 / 8 | 8 / 11 | 1M | 0M |
| Q1 2026 | 31 | 1M | 8.2% | 12 / 10 | 1 / 8 | 0M | 0M |
| Q4 2025 | 28 | 1M | 5.9% | 6 / 9 | 7 / 11 | 0M | 1M |
| Q3 2025 | 33 | 1M | 9.6% | 7 / 13 | 4 / 3 | 0M | 0M |
| Q2 2025 | 29 | 1M | 8.8% | 9 / 7 | 4 / 5 | 0M | 0M |
| Q1 2025 | 25 | 1M | 7.7% | 4 / 8 | 6 / 6 | 0M | 0M |
| Q4 2024 | 27 | 1M | 6.8% | 8 / 7 | 5 / 3 | 0M | 0M |
| Q3 2024 | 22 | 1M | 6.4% | 4 / 7 | 4 / 8 | 1M | 0M |
| Q2 2024 | 27 | 0M | 2.9% | 7 / 7 | 6 / 4 | 0M | 0M |
| Q1 2024 | 24 | 0M | 3.0% | 2 / 8 | 6 / 6 | 0M | 0M |
| Q4 2023 | 28 | 0M | 2.4% | 4 / 10 | 5 / 6 | 0M | 0M |
| Q3 2023 | 30 | 0M | 2.3% | 3 / 5 | 8 / 6 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
5 funds held VNRX in Q2 2026, 53% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of VNRX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 50,684 | 0.37% | $68.42K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 31,776 | 0.23% | $84.84K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 7,037 | 0.05% | $18.79K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 5,775 | 0.04% | $15.42K | 0.00% | May 31, 2026 |
| Total Stock Market Index Trust | 588 | 0.00% | $794 | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Cameron John Reynolds | President and CEO, Director | 4,157,341 | 30.46% | Feb 27, 2026 |
| Ann-Louise Batchelor | Group Chief Marketing Officer | 29,257 | 0.21% | Oct 23, 2026 |
| Gaetan Michel | Chief Operating Officer | 12,232 | 0.09% | Sep 30, 2026 |
| Gael Forterre | Chief Commercial Officer | 18,159 | 0.13% | Sep 30, 2026 |
| Nicholas Plummer | GC - Volition Diagnostics | 407,267 | 2.98% | Mar 19, 2026 |
| Rodney Gerard Rootsaert | Secretary | 1,281,711 | 9.39% | Mar 19, 2026 |
| Jacob Vincent Micallef | Chief Scientific Officer | 665,292 | 4.87% | Mar 19, 2026 |
| Terig Hughes | Chief Financial Officer | 684,970 | 5.02% | Feb 27, 2026 |
| Jasmine Kway | CEO - Singapore Volition | 429,014 | 3.14% | Feb 27, 2026 |
| Salvatore Thomas Butera | CEO - Volition Veterinary | 375,203 | 2.75% | Jan 23, 2026 |
| Andrew Retter | Chief Medical Officer | 146,568 | 1.07% | Nov 4, 2025 |
| Guy Archibald Innes | Director | 3,317,974 | 24.31% | Feb 27, 2026 |
| Ethel Rubin | Director | 252,948 | 1.85% | Feb 27, 2026 |
| Kim Nguyen | Director | 336,372 | 2.46% | Feb 27, 2026 |
| Timothy I. Still | Director | 1,625,458 | 11.91% | Jan 23, 2026 |
| Phillip Barnes | Director | 67,368 | 0.49% | Jan 23, 2026 |
| Mickie Henshall | Director | 44,206 | 0.32% | Jan 23, 2026 |
| Alan Colman | Director | 257,364 | 1.89% | Jan 23, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ann-Louise Batchelor Group Chief Marketing Officer | Oct 21, 2026 | Award | +12,000 | – | – | 27,786 |
| Gael Forterre Chief Commercial Officer | Sep 28, 2026 | Tax withholding | −284 | $0.25 | $71 | 16,284 |
| Gaetan Michel Chief Operating Officer | Sep 28, 2026 | Tax withholding | −608 | $0.25 | $152 | 12,232 |
| Gael Forterre Chief Commercial Officer | Mar 17, 2026 | Tax withholding | −5,251 | $0.19 | $998 | 331,338 |
| Rodney Gerard Rootsaert Secretary | Mar 17, 2026 | Tax withholding | −3,948 | $0.19 | $750 | 273,993 |
| Nicholas Plummer GC - Volition Diagnostics | Mar 17, 2026 | Tax withholding | −7,003 | $0.19 | $1.33K | 407,267 |
| Jacob Vincent Micallef Chief Scientific Officer | Mar 17, 2026 | Tax withholding | −5,310 | $0.19 | $1.01K | 572,179 |
| Gael Forterre Chief Commercial Officer | Mar 1, 2026 | Tax withholding | −2,283 | $0.21 | $479 | 336,589 |
| Nicholas Plummer GC - Volition Diagnostics | Mar 1, 2026 | Tax withholding | −5,867 | $0.21 | $1.23K | 414,270 |
| Rodney Gerard Rootsaert Secretary | Mar 1, 2026 | Tax withholding | −3,321 | $0.21 | $697 | 277,941 |
| Terig Hughes Chief Financial Officer | Feb 26, 2026 | Award | +202,000 | – | – | 684,970 |
| Rodney Gerard Rootsaert Secretary | Feb 26, 2026 | Award | +119,000 | – | – | 281,262 |
| Nicholas Plummer GC - Volition Diagnostics | Feb 26, 2026 | Award | +187,000 | – | – | 420,137 |
| Jacob Vincent Micallef Chief Scientific Officer | Feb 26, 2026 | Award | +149,000 | – | – | 577,489 |
| Guy Archibald Innes Director | Feb 26, 2026 | Award | +178,000 | – | – | 1,252,967 |
| Ann-Louise Batchelor Group Chief Marketing Officer | Feb 26, 2026 | Award | +142,000 | – | – | 324,072 |
| Cameron John Reynolds President and CEO, Director | Feb 26, 2026 | Award | +486,000 | – | – | 3,115,547 |
| Jasmine Kway CEO - Singapore Volition | Feb 26, 2026 | Award | +173,000 | – | – | 418,614 |
| Ethel Rubin Director | Feb 26, 2026 | Award | +178,000 | – | – | 252,948 |
| Kim Nguyen Director | Feb 26, 2026 | Award | +178,000 | – | – | 305,816 |
| Gael Forterre Chief Commercial Officer | Feb 26, 2026 | Award | +149,000 | – | – | 338,872 |
| Gael Forterre Chief Commercial Officer | Feb 1, 2026 | Tax withholding | −2,010 | $0.29 | $583 | 189,872 |
| Nicholas Plummer GC - Volition Diagnostics | Feb 1, 2026 | Tax withholding | −5,647 | $0.29 | $1.64K | 233,137 |
| Rodney Gerard Rootsaert Secretary | Feb 1, 2026 | Tax withholding | −3,196 | $0.29 | $927 | 162,262 |
| Terig Hughes Chief Financial Officer | Jan 22, 2026 | Award | +49,200 | – | – | 482,970 |
| Gael Forterre Chief Commercial Officer | Jan 22, 2026 | Award | +38,100 | – | – | 191,882 |
| Salvatore Thomas Butera CEO - Volition Veterinary | Jan 22, 2026 | Award | +53,400 | – | – | 375,203 |
| Jacob Vincent Micallef Chief Scientific Officer | Jan 22, 2026 | Award | +35,400 | – | – | 428,489 |
| Guy Archibald Innes Director | Jan 22, 2026 | Award | +12,000 | – | – | 1,074,967 |
| Rodney Gerard Rootsaert Secretary | Jan 22, 2026 | Award | +28,200 | – | – | 165,458 |
| Jasmine Kway CEO - Singapore Volition | Jan 22, 2026 | Award | +42,000 | – | – | 245,614 |
| Phillip Barnes Director | Jan 22, 2026 | Award | +12,000 | – | – | 67,368 |
| Kim Nguyen Director | Jan 22, 2026 | Award | +12,000 | – | – | 127,816 |
| Ann-Louise Batchelor Group Chief Marketing Officer | Jan 22, 2026 | Award | +33,900 | – | – | 182,072 |
| Timothy I. Still Director | Jan 22, 2026 | Award | +90,000 | – | – | 1,625,458 |
| Nicholas Plummer GC - Volition Diagnostics | Jan 22, 2026 | Award | +44,700 | – | – | 238,784 |
| Mickie Henshall Director | Jan 22, 2026 | Award | +12,000 | – | – | 44,206 |
| Ethel Rubin Director | Jan 22, 2026 | Award | +12,000 | – | – | 74,948 |
| Alan Colman Director | Jan 22, 2026 | Award | +12,000 | – | – | 257,364 |
| Cameron John Reynolds President and CEO, Director | Jan 22, 2026 | Award | +74,700 | – | – | 2,629,547 |
| Cameron John Reynolds President and CEO, Director | Nov 17, 2025 | Buy | +20,000 | $0.35 | $7.00K | 2,554,847 |
| Rodney Gerard Rootsaert Secretary | Nov 1, 2025 | Tax withholding | −3,197 | $0.43 | $1.37K | 137,258 |
| Nicholas Plummer GC - Volition Diagnostics | Nov 1, 2025 | Tax withholding | −5,647 | $0.43 | $2.43K | 194,084 |
| Salvatore Thomas Butera CEO - Volition Veterinary | Nov 1, 2025 | Tax withholding | −4,648 | $0.43 | $2.00K | 321,803 |
| Andrew Retter Chief Medical Officer | Nov 1, 2025 | Tax withholding | −4,588 | $0.43 | $1.97K | 146,568 |
| Gael Forterre Chief Commercial Officer | Nov 1, 2025 | Tax withholding | −1,753 | $0.43 | $754 | 153,782 |
| Guy Archibald Innes Director | Oct 14, 2025 | Buy | +96,153 | $0.51 | $49.04K | 1,062,967 |
| Timothy I. Still Director | Oct 14, 2025 | Buy | +48,076 | $0.51 | $24.52K | 1,535,458 |
| Cameron John Reynolds President and CEO, Director | Oct 14, 2025 | Buy | +110,000 | $0.51 | $56.10K | 2,534,847 |
| Salvatore Thomas Butera CEO - Volition Veterinary | Oct 4, 2025 | Tax withholding | −5,834 | $0.65 | $3.79K | 326,451 |
| Gaetan Michel Chief Operating Officer | Oct 4, 2025 | Tax withholding | −12,333 | $0.65 | $8.02K | 256,746 |
| Ann-Louise Batchelor Group Chief Marketing Officer | Oct 4, 2025 | Tax withholding | −6,110 | $0.65 | $3.97K | 148,172 |
| Jacob Vincent Micallef Chief Scientific Officer | Oct 4, 2025 | Tax withholding | −5,850 | $0.65 | $3.80K | 393,089 |
| Gael Forterre Chief Commercial Officer | Oct 4, 2025 | Tax withholding | −5,389 | $0.65 | $3.50K | 155,535 |
| Rodney Gerard Rootsaert Secretary | Oct 4, 2025 | Tax withholding | −4,620 | $0.65 | $3.00K | 140,455 |
| Nicholas Plummer GC - Volition Diagnostics | Oct 4, 2025 | Tax withholding | −8,146 | $0.65 | $5.29K | 199,731 |
| Gaetan Michel Chief Operating Officer | Sep 28, 2025 | Tax withholding | −11,362 | $0.61 | $6.93K | 369,079 |
| Gael Forterre Chief Commercial Officer | Sep 28, 2025 | Tax withholding | −5,503 | $0.61 | $3.36K | 160,924 |
| Rodney Gerard Rootsaert Secretary | Sep 28, 2025 | Tax withholding | −4,158 | $0.61 | $2.54K | 145,075 |
| Salvatore Thomas Butera CEO - Volition Veterinary | Sep 28, 2025 | Tax withholding | −5,230 | $0.61 | $3.19K | 332,285 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of VolitionRx's stock actually held short. Settlement fails (shares not delivered on time) peaked at 7,068,460 shares on Aug 28, 2026 over the last 90 days.
See a number that looks wrong?